/LLAI.L
LLAI.L Stock - LungLife AI, Inc.
Healthcare|Medical - Diagnostics & ResearchLSE
$4.15-2.35%
$0.10 (-2.35%) • May 28
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.57
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LLAI.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.11 – $4.19
TARGET (TP)$4.77
STOP LOSS$3.82
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.37
52W High$21.70
52W Low$0.80
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $46,000 | $24,000 | $195,566 | $205,180 | $136,492 |
| Gross Profit | $46,000 | $24,000 | $99,297 | $17,000 | $-13,398 |
| Gross Margin | 100.0% | 100.0% | 50.8% | 8.3% | -9.8% |
| Operating Income | $-5,632,000 | $-7,638,000 | $-5,344,100 | $-4,061,837 | $-3,412,208 |
| Net Income | $-5,413,000 | $-7,606,000 | $-7,444,188 | $-5,616,209 | $-4,736,125 |
| Net Margin | -11767.4% | -31691.7% | -3806.5% | -2737.2% | -3469.9% |
| EPS | $-0.21 | $-0.30 | $-0.47 | $-0.22 | $-0.19 |
Company Overview
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LLAI.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.05
Q3 2024
EPS Surprise History
Q4 20
No data
Q3 21
No data
Q1 22
No data
Q3 22
No data
Q1 23
No data
Q3 23
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 22, 2024 | — | $-0.05 | — | — |
Q2 2024 | Apr 4, 2024 | — | $-0.08 | — | — |
Q3 2023 | Aug 8, 2023 | — | $-0.09 | — | — |
Q1 2023 | Feb 20, 2023 | — | $-0.10 | — | — |
Q3 2022 | Sep 26, 2022 | — | $-0.14 | — | — |
Q1 2022 | Mar 28, 2022 | — | $-0.08 | — | — |
Q3 2021 | Sep 9, 2021 | — | $-0.69 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.31 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.02 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.07 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.07 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.05 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.05 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LLAI.L
What is LLAI.L's current stock price?
LungLife AI, Inc. (LLAI.L) is currently trading at $4.15 per share. The stock has moved -2.35% today.
What is the analyst price target for LLAI.L?
No analyst price targets are currently available for this stock.
What sector is LungLife AI, Inc. in?
LungLife AI, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the LSE exchange.
What is LLAI.L's market cap?
LungLife AI, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does LLAI.L pay dividends?
No, LungLife AI, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCLAI.L
Cel AI PLC
$0.13
Mkt Cap: $0.1B
DVRG.L
DeepVerge plc
$0.15
Mkt Cap: $0.1B
HELD.L
Hellenic Dynamics Plc
$0.95
Mkt Cap: $0.1B
KNB.L
Kanabo Group Plc
$0.23
Mkt Cap: $0.1B
LLA.L
LungLife AI, Inc.
$5.00
Mkt Cap: $0.1B
OCTP.L
Oxford Cannabinoid Technologies Holdings Plc
$0.12
Mkt Cap: $0.1B
ONC.L
Oncimmune Holdings plc
$1.14
Mkt Cap: $0.1B
OVB.L
Ovoca Bio plc
$1.15
Mkt Cap: $0.1B
RENE.L
ReNeuron Group plc
$3.38
Mkt Cap: $0.2B
TLY.L
Totally plc
$0.24
Mkt Cap: $0.0B
Explore stocks similar to LLAI.L for comparison